Sangamo Therapeutics Inc (NASDAQ: SGMO) is -3.08% lower on its value in year-to-date trading and has touched a low of $0.30 and a high of $3.18 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SGMO stock was last observed hovering at around $1.04 in the last trading session, with the day’s loss setting it -0.05%.
Currently trading at $0.99, the stock is -4.97% and -19.43% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.18 million and changing -4.94% at the moment leaves the stock -13.47% off its SMA200. SGMO registered -2.12% loss for a year compared to 6-month gain of 31.59%.
The stock witnessed a -22.16% loss in the last 1 month and extending the period to 3 months gives it a -49.04%, and is 7.40% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 13.92% over the week and 10.29% over the month.
Sangamo Therapeutics Inc (SGMO) has around 405 employees, a market worth around $206.27M and $52.29M in sales. Profit margin for the company is -260.33%. Distance from 52-week low is 225.20% and -68.90% from its 52-week high. The company has generated returns on investments over the last 12 months (-203.60%).
with sales reaching $11.7M over the same period.The EPS is expected to grow by 68.41% this year, but quarterly earnings will post -64.81% year-over-year. Quarterly sales are estimated to grow 472.97% in year-over-year returns.
Sangamo Therapeutics Inc (SGMO) Top Institutional Holders
The shares outstanding are 208.62M, and float is at 199.25M with Short Float at 12.78%.
The top institutional shareholder in the company is WASATCH ADVISORS LP with over 20.09 million shares valued at $7.2 million. The investor’s holdings represent 9.8509% of the SGMO Shares outstanding. As of 2024-06-30, the second largest holder is ARMISTICE CAPITAL, LLC with 14.06 million shares valued at $5.04 million to account for 6.894 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 11.9 million shares representing 6.5977% and valued at over $4.26 million, while BLACKROCK INC. holds 2.6078 of the shares totaling 4.7 million with a market value of $1.69 million.
Sangamo Therapeutics Inc (SGMO) Insider Activity
#####
